Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges

By afschroeder • February 19, 2026

Rana AI, Zheng L, Castillo-Mancilla J, Bao Y, Sieczkarski S, Brooks KM, Lake JE, Fichtenbaum C, Heath SL, Belaunzaran-Zamudio PF, Klingman K, Fox L, Morton T, Stirratt M, Li JZ, Acosta EP, Venuto C, Galáarraga O, Shoptaw S, Wohl D, Green M, Beijer C, Ferbas K, Jennings C, Shin K, Collahua R, Dorosh M, Wannamaker P, D'Amico R, Smith K, Spreen W, Vandermeulen K, Van Solingen-Ristea R, Wimbish C, Tashima KT, Landovitz RJ; ACTG A5359 LATITUDE Trial Team. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. N Engl J Med. 2026 Feb 18. doi: 10.1056/NEJMoa2508228. Epub ahead of print. PMID: 41707171.

Tags: Infectious Diseases, Publications

IFNgamma-induced memory in human macrophages is sustained by the durability of cytokine signaling itself

Gorin A, Niu S, Harriott N, Koduvayur V, Cheng QJ, Hoffmann A. IFNγ-induced memory in human macrophages is sustained by the durability of cytokine signaling[...]

Deciphering the etiology of the 2024 outbreak of undiagnosed febrile illness in Panzi, Democratic Republic of the Congo

Wawina-Bokalanga T, Makangara-Cigolo JC, Ola-Mpumbe R, Lokilo E, Mwakisenda-Tshakotsho F, Delphine M, Kahindo I, Tshonaka-Nkololo A, Vakaniaki EH, Loman N, Houben S, Lumembe-Numbi R, Kinganda-Lusamaki[...]

Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses

Smith D, Weir IR, Ramirez S, Coelho CH, Manne-Goehler J, Aziz M, Benson CA, Wu X, Hyer R, Dhillon PK, Faraji F, Bloom N, Myers[...]